340 related articles for article (PubMed ID: 24992549)
1. Avoidance of nonsteroidal anti-inflammatory drugs after negative provocation tests in urticaria/angioedema reactions: Real-world experience.
Bommarito L; Zisa G; Riccobono F; Villa E; D'Antonio C; Calamari AM; Poppa M; Moschella A; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2014; 35(4):303-6. PubMed ID: 24992549
[TBL] [Abstract][Full Text] [Related]
2. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
[TBL] [Abstract][Full Text] [Related]
3. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.
Blanca-Lopez N; J Torres M; Doña I; Campo P; Rondón C; Seoane Reula ME; Salas M; Canto G; Blanca M
Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883
[TBL] [Abstract][Full Text] [Related]
4. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.
Arikoglu T; Aslan G; Yildirim DD; Batmaz SB; Kuyucu S
Allergol Int; 2017 Jul; 66(3):418-424. PubMed ID: 27865769
[TBL] [Abstract][Full Text] [Related]
6. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study.
Doña I; Blanca-López N; Torres MJ; Gómez F; Fernández J; Zambonino MA; Monteseirín FJ; Canto G; Blanca M; Cornejo-García JA
Allergy; 2014 Apr; 69(4):438-44. PubMed ID: 24372026
[TBL] [Abstract][Full Text] [Related]
7. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs.
Defrance C; Bousquet PJ; Demoly P
Allergy; 2011 Nov; 66(11):1410-4. PubMed ID: 21722141
[TBL] [Abstract][Full Text] [Related]
9. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
Kowalski ML; Woessner K; Sanak M
J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
[TBL] [Abstract][Full Text] [Related]
10. Negative predictive value of provocation tests for nonsteroidal anti-inflammatory drugs in children.
Topal OY; Ilknur KC; Irem YT; Muge T; Ersoy C; Betul K; Emine DM
Allergy Asthma Proc; 2020 Jul; 41(4):285-289. PubMed ID: 32605698
[No Abstract] [Full Text] [Related]
11. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
12. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G
J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343
[TBL] [Abstract][Full Text] [Related]
13. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
[TBL] [Abstract][Full Text] [Related]
14. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
[TBL] [Abstract][Full Text] [Related]
15. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
[TBL] [Abstract][Full Text] [Related]
16. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and Updated Classification of Acute Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAID-Exacerbated or -Induced Food Allergy.
Romano A; Gaeta F; Caruso C; Fiocchi A; Valluzzi RL
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1843-1853.e1. PubMed ID: 36997117
[TBL] [Abstract][Full Text] [Related]
18. Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity.
Yilmaz Topal O; Kulhas Celik I; Turgay Yagmur I; Toyran M; Civelek E; Karaatmaca B; Kocabas CN; Dibek Misirlioglu E
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):202-207. PubMed ID: 32294526
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
Saff RR; Banerji A
Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
[TBL] [Abstract][Full Text] [Related]
20. Safety and outcomes of "at-home self-provocation tests" in patients with mild nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
Park SY; Yoo Y; Huh JY; Lee D; Kim K; Jung JW; Choi JC; Lee JH; Song WJ; Kim TB; Cho YS; Kwon HS
Ann Allergy Asthma Immunol; 2023 Sep; 131(3):356-361. PubMed ID: 37098402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
